A

Atrys Health SA
MAD:ATRY

Watchlist Manager
Atrys Health SA
MAD:ATRY
Watchlist
Price: 3.15 EUR -1.87% Market Closed
Market Cap: 239.2m EUR
Have any thoughts about
Atrys Health SA?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

High Profitability Stocks
Health Care Industry

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Atrys Health SA

Revenue
190.8m EUR
Cost of Revenue
-63.1m EUR
Gross Profit
127.6m EUR
Operating Expenses
-126m EUR
Operating Income
1.7m EUR
Other Expenses
-40.7m EUR
Net Income
-39.1m EUR

Margins Comparison
Atrys Health SA Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
ES
Atrys Health SA
MAD:ATRY
239.2m EUR
67%
1%
-20%
US
Cigna Corp
NYSE:CI
88B USD
12%
4%
2%
US
Cigna Group
XMUN:CGN
80.2B EUR
12%
4%
2%
US
CVS Health Corp
NYSE:CVS
70.9B USD
15%
4%
2%
DE
Fresenius Medical Care AG
XMUN:FME
21B EUR
25%
7%
3%
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.9B EUR
23%
6%
-5%
US
Laboratory Corporation of America Holdings
NYSE:LH
19.1B USD
28%
9%
3%
US
Quest Diagnostics Inc
NYSE:DGX
17.3B USD
33%
14%
9%
MY
Hong Seng Consolidated Bhd
KLSE:HONGSENG
58.5B MYR
-120%
-420%
-366%
US
DaVita Inc
NYSE:DVA
11.9B USD
33%
15%
7%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.5B EUR
25%
7%
3%
Country ES
Market Cap 239.2m EUR
Gross Margin
67%
Operating Margin
1%
Net Margin
-20%
Country US
Market Cap 88B USD
Gross Margin
12%
Operating Margin
4%
Net Margin
2%
Country US
Market Cap 80.2B EUR
Gross Margin
12%
Operating Margin
4%
Net Margin
2%
Country US
Market Cap 70.9B USD
Gross Margin
15%
Operating Margin
4%
Net Margin
2%
Country DE
Market Cap 21B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
3%
Country DE
Market Cap 18.9B EUR
Gross Margin
23%
Operating Margin
6%
Net Margin
-5%
Country US
Market Cap 19.1B USD
Gross Margin
28%
Operating Margin
9%
Net Margin
3%
Country US
Market Cap 17.3B USD
Gross Margin
33%
Operating Margin
14%
Net Margin
9%
Country MY
Market Cap 58.5B MYR
Gross Margin
-120%
Operating Margin
-420%
Net Margin
-366%
Country US
Market Cap 11.9B USD
Gross Margin
33%
Operating Margin
15%
Net Margin
7%
Country DE
Market Cap 10.5B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
3%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Atrys Health SA Competitors

Country Company Market Cap ROE ROA ROCE ROIC
ES
Atrys Health SA
MAD:ATRY
239.2m EUR
-13%
-6%
0%
0%
US
Cigna Corp
NYSE:CI
88B USD
9%
2%
9%
7%
US
Cigna Group
XMUN:CGN
80.2B EUR
9%
2%
9%
7%
US
CVS Health Corp
NYSE:CVS
70.9B USD
10%
3%
8%
5%
DE
Fresenius Medical Care AG
XMUN:FME
21B EUR
4%
2%
5%
3%
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.9B EUR
-6%
-2%
3%
1%
US
Laboratory Corporation of America Holdings
NYSE:LH
19.1B USD
5%
2%
8%
5%
US
Quest Diagnostics Inc
NYSE:DGX
17.3B USD
13%
6%
10%
8%
MY
Hong Seng Consolidated Bhd
KLSE:HONGSENG
58.5B MYR
-20%
-15%
-21%
-21%
US
DaVita Inc
NYSE:DVA
11.9B USD
104%
5%
13%
9%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.5B EUR
4%
2%
5%
3%
Country ES
Market Cap 239.2m EUR
ROE
-13%
ROA
-6%
ROCE
0%
ROIC
0%
Country US
Market Cap 88B USD
ROE
9%
ROA
2%
ROCE
9%
ROIC
7%
Country US
Market Cap 80.2B EUR
ROE
9%
ROA
2%
ROCE
9%
ROIC
7%
Country US
Market Cap 70.9B USD
ROE
10%
ROA
3%
ROCE
8%
ROIC
5%
Country DE
Market Cap 21B EUR
ROE
4%
ROA
2%
ROCE
5%
ROIC
3%
Country DE
Market Cap 18.9B EUR
ROE
-6%
ROA
-2%
ROCE
3%
ROIC
1%
Country US
Market Cap 19.1B USD
ROE
5%
ROA
2%
ROCE
8%
ROIC
5%
Country US
Market Cap 17.3B USD
ROE
13%
ROA
6%
ROCE
10%
ROIC
8%
Country MY
Market Cap 58.5B MYR
ROE
-20%
ROA
-15%
ROCE
-21%
ROIC
-21%
Country US
Market Cap 11.9B USD
ROE
104%
ROA
5%
ROCE
13%
ROIC
9%
Country DE
Market Cap 10.5B EUR
ROE
4%
ROA
2%
ROCE
5%
ROIC
3%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top